Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
Thomas P. Farrell
Advertisement
Thomas P. Farrell is Global Director, Immediate Release Technologies, at Colorcon Inc. (PA, USA).
Articles by Thomas P. Farrell
Advertisement
Latest Updated Articles
Narrowing the gap between clinical capsule formulations and commercial film-coated tabletsPublished: May 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
